Other Health

The 'Anything Menopause' project is designed for the three million Australian women who are experiencing menopause symptoms.

"I have been incredibly grateful for the opportunity over the last three years to work closely with the incredible stakeholders and advocates in the health, aged care and sport sectors, and to hold the Albanese Labor Government to account on these important areas of social policy," said Anne Senator Ruston.

The Pharmacy Guild has called for "greater scrutiny and consideration" of the ownership models in Australia's health system following the collapse of private hospital provider Healthscope.

It is appropriate to describe the proposed PBS levy as a tax. As a tax, it would need to be separately legislated by the parliament, providing the industry and other stakeholders with an opportunity to raise the potential risks and unintended consequences.

Cell therapy company Cartherics has announced that chief operating officer Dr Ian Nisbet will present at the upcoming 2025 BIO International Convention in June.

Opposition Leader Sussan Ley has confirmed that Senator Anne Ruston has retained the shadow health portfolio with the addition of disability and the National Disability Insurance Scheme.

How can you not be sceptical about a system in which patients suffer and sometimes die waiting for the one-sided negotiation of a price via contested and rigged economic models?

Zosurabalpin could be the first drug in five decades capable of addressing difficult-to-treat Acinetobacter or any other Gram-negative bacteria, which disproportionately impact patients in hospital, causing infections such as pneumonia and sepsis.

Naseem Ali, medical affairs lead for XTANDI at Astellas Australia, said, “Prostate cancer is currently the most diagnosed cancer in Australia and continues to be a major health burden, but these findings signal a meaningful step forward in improving outcomes for men facing the disease."

A leadership transition for the Medical Affairs Professionals of Australasia, with current president, AbbVie's Lauren Pasfield, taking extended leave for her new child.

The New South Wales Government has announced it will make treatment for attention-deficit hyperactivity disorder more accessible through general practitioners.

Immutep (ASX:IMM) has announced that the investigator-initiated EFTISARC-NEO Phase 2 trial evaluating its eftilagimod alpha with radiotherapy plus MSD's KEYTRUDA (pembrolizumab) in the neoadjuvant setting for resectable soft tissue sarcoma has met its primary endpoint.